v3.19.2
Stockholders' Deficit (Details 1) - Series RX-2 Preferred Stock Warrant [Member]
6 Months Ended
Jun. 30, 2019
USD ($)
shares
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 490,658
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 981,316
Employee [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 29,003
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 58,006
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 5,800,600
Outside Director [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 149,021
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 298,042
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 29,804,200
Outside Director One [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 51,924
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 103,848
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 10,384,800
consultant [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 87,009
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 174,018
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 17,401,800
consultant One [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 81,651
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 163,302
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 16,330,200
consultant Two [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 92,050
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 184,100
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 18,410,000
Preferred Stock Warrant [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 490,658
Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable 981,316
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 98,131,600